Oncology Services India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.50 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 2.50 M
- Revenue Growth %
- Profit Growth 77.95%
- Ebitda 81.42%
- Net Worth -32.82%
- Total Assets -30.68%
About Oncology Services India
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100GJ2008PLC054736
-
Company No.
054736
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
11 Aug 2008
-
Date of AGM
27 Aug 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Oncology Services India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Urmish Chudgar
|
Director | 11-Aug-2008 | Current |
|
Nimish Chudgar
|
Director | 15-Sep-2011 | Current |
|
Shail Chudgar
|
Director | 27-Mar-2012 | Current |
Financial Performance of Oncology Services India.
Oncology Services India Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 77.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 32.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oncology Services India?
In 2017, Oncology Services India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Astron Packaging LimitedUrmish Chudgar and Nimish Chudgar are mutual person
-
Sm Herbals Private LimitedNimish Chudgar is a mutual person
-
Advanced Transfusion Medicine Research FoundationUrmish Chudgar is a mutual person
-
Accord Healthcare LimitedUrmish Chudgar and Nimish Chudgar are mutual person
-
Intas Pharmaceuticals LimitedUrmish Chudgar and Nimish Chudgar are mutual person
-
Unipath Specialty Laboratory LimitedUrmish Chudgar is a mutual person
Charges (Loans)
₹0
₹0.25 Cr
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Dec 2009 | Union Bank Of India | ₹2.50 M | Satisfied |
How Many Employees Work at Oncology Services India?
Oncology Services India has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oncology Services India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncology Services India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
